The ChatGPT-maker OpenAI will license Synopsys' chip design software to develop GPT-Synopsys, a specialized AI model the ...
Hansa Biopharma will use Cradle’s AI protein-engineering platform to design autoimmune drug candidates and shorten cycles of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results